New Sheffield nursing course aims to plug NHS workforce gaps
The shortage of general practice nurses has been put down to a number of factors, including ageing, outdated attitudes, the preference for experienced nurses, Covid, pay, conditions and morale.Sarah Dodsworth from the RCN Yorkshire & the Humber said: "General practice nursing staff are paramount to the success of the NHS [yet] almost a third of GP nursing staff went without a pay rise last year. So it's utterly unsurprising that morale is poor."Dr Lewis added: "We've known about about the demographics of the practice nurses for a while now - [back in] 2016 we knew there was a problem then."The hardest part was convincing GPs, and Covid set us back five years."
The course, being offered in Sheffield and at University Campus Doncaster, is taught by "nurse educators" currently working in general practice.Module lead Emma Parker said "Traditionally there is this thought that nurses need lots of years of experience - this module [tries to] dispel these myths and encourage newly qualified nurses into primary health nursing."Iona Smith ,33, who is in the final year of her nursing course, said she wanted to pursue a career in general practice after enjoying her GP placement.She said: "I loved it. I flourished and my confidence grew."There's a lot of us who want to go down that route, which means that there's going to be a workforce for longer, which is good."A spokesperson for NHS England said it was working to expand access to and awareness of practice nursing as part of the government's 10-year plan, adding that more than 300 nurses had taken part in nursing programmes such as the one at Sheffield Hallam University.
Listen to highlights from South Yorkshire on BBC Sounds, catch up with the latest episode of Look North or tell us a story you think we should be covering here.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
an hour ago
- Daily Mail
Are YOUR dizzy spells being caused by hidden nervous system problems that GPs often fail to spot... and could the cure be a 30p pill?
For more than 20 years, mother-of-two Kerry Clayton endured dizzy spells, fainting and constant light-headedness – only to have her concerns repeatedly dismissed by doctors. Her symptoms first appeared in her teens when she fainted during an exam. At the time, it was put down to stress. But the episodes kept happening – at work, in busy crowds – until they became, as she puts it, 'part of everyday life'.
Daily Mail
an hour ago
- Daily Mail
Fat jabs like Ozempic and Mounjaro threaten to push up pension age as life expectancy rises
The spread of 'fat jabs' such as Ozempic could lead to a rise in the state pension age because previously obese workers will live longer than expected, Government advisers have warned. With more than 1.5 million people now using weight-loss drugs in the UK, the number-crunchers say that actuarial calculations about life expectancy – and therefore the bill faced by the Department for Work and Pensions – will have to be adjusted. Users of the drugs, which also include Mounjaro and Wegovy, typically lose about 15 per cent of their body weight, leading to knock-on health benefits such as lower cholesterol levels and reduced blood pressure. Health Secretary Wes Streeting aims to widen the availability of the drugs on the NHS to lessen the burden on the Health Service and boost employment, arguing that 'our widening waistbands' are 'holding back our economy'. Illness as a result of obesity causes people to take an extra four sick days a year on average. But a Government source told The Mail on Sunday: 'Obviously everyone can see the health benefits. But some people in the Treasury are worried about the impact on the pension crisis. Obesity is a big killer. 'And if people are starting to live a lot longer because they're not overweight that's quickly going to become an issue. Especially if we're going to see it regularly being prescribed on the NHS, as Wes is advocating.' The NHS currently offers the medicines for the management of obesity in certain patients. With more than 1.5 million people now using weight-loss drugs in the UK, the number-crunchers say that actuarial calculations about life expectancy – and therefore the bill faced by the Department for Work and Pensions – will have to be adjusted (file image) The state pension age will officially rise next year from 66 to 67, and then again to 68 between 2044 and 2046 – although growing pressure on public funds means an upcoming pension review by Work and Pensions Secretary Liz Kendall could hike that age further. Chancellor Rachel Reeves is facing a £50billion 'fiscal hole' in the public finances she will need to close in Autumn's Budget: measures considered include tighter inheritance tax rules and an increase in 'sin taxes' on tobacco and gambling. The triple lock protection for the state pension is also becoming a growing burden, with spiking inflation predicted to push the full amount to £12,451 next year – a £478 rise from its current level of £11,973. According to the forecasts, the state pension will cost the Exchequer £151.42 billion that year – £430 million higher than the £150.99 billion bill anticipated as a result of previous Bank Of England inflation forecasts. Mr Streeting hopes the weight-loss jabs will ease the burden on the NHS' budget, which will rise by 3.3 per cent next year to £192 billion.
Daily Mail
2 hours ago
- Daily Mail
Surge in cannabis-induced psychotic episodes across the UK as potency of strains has increased
Cannabis-induced psychosis is becoming increasingly common across the UK, a leading psychiatrist has warned. The widely used class B drug – also known as marijuana or weed – can cause dependency, and, in the year to March 2024, 2.3million people in the UK reported using it. But while regular use has more than halved in the past two decades, the number of cannabis-induced psychosis episodes has spiked as varieties on sale have become stronger. Those experiencing a psychotic episode commonly have symptoms such as hallucinations, dissociation or unusual changes in behaviour. And while these resolve in most cases, side-effects can last for years. Studies show cannabis can even trigger schizophrenia – a chronic mental health condition characterised by psychotic episodes where individuals lose touch with reality, experiencing delusions and hallucinations. Dr Niall Campbell, a consultant psychiatrist at the Priory rehabilitation centre, warns of a deepening public health issue, stemming from easy online access to highly potent forms of the drug known as 'skunk'. Made from unpollinated cannabis plants which naturally contain higher levels of THC – the main psychoactive ingredient – skunk greatly increases the risk of paranoia and hallucinations. 'There has been a visible rise in the number of people needing intensive support for psychosis as a result of cannabis use,' said Dr Campbell. 'I don't think this is surprising given how easy skunk is to buy. What begins with smoking a few 'joints' and feeling a bit paranoid can easily escalate. Over time people can reach a psychotic state which won't go away, even if they stop smoking – they can become very depressed or suicidal.' It comes after the London Drugs Commission released a report earlier this year calling for more services to tackle cannabis addiction.
